Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2).

[1]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[2]  U. Rinas,et al.  Susceptibility towards intramolecular disulphide-bond formation affects conformational stability and folding of human basic fibroblast growth factor. , 1998, The Biochemical journal.

[3]  R. Langer,et al.  A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. , 1997, Journal of pharmaceutical sciences.

[4]  B. Subramaniam,et al.  Pharmaceutical processing with supercritical carbon dioxide. , 1997, Journal of pharmaceutical sciences.

[5]  A. Harvey,et al.  In Vitro Assessment of the Biological Activity of Basic Fibroblast Growth Factor Released from Various Polymers and Biomatrices , 1997, Journal of biomaterials applications.

[6]  R Langer,et al.  Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.

[7]  S J Prestrelski,et al.  Precipitation of proteins in supercritical carbon dioxide. , 1996, Journal of pharmaceutical sciences.

[8]  Frank V. Bright,et al.  Specific Intermolecular Interaction of Carbon Dioxide with Polymers , 1996 .

[9]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[10]  R Langer,et al.  Fabricating tubular devices from polymers of lactic and glycolic Acid for tissue engineering. , 1995, Tissue engineering.

[11]  P. Debenedetti,et al.  Secondary structure characterization of microparticulate insulin powders. , 1994, Journal of pharmaceutical sciences.

[12]  D. Mosher,et al.  Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. , 1994, The Journal of clinical investigation.

[13]  M. J. Hickey,et al.  An improved matrix-type controlled release system for basic fibroblast growth factor. , 1994, Biochemical and biophysical research communications.

[14]  R Langer,et al.  Design and Fabrication of Biodegradable Polymer Devices to Engineer Tubular Tissues , 1994, Cell transplantation.

[15]  D. J. Dixon,et al.  Formation of microporous polymer fibers and oriented fibrils by precipitation with a compressed fluid antisolvent , 1993 .

[16]  G. Lim,et al.  Formation of microparticulate protein powder using a supercritical fluid antisolvent , 1993, Biotechnology and bioengineering.

[17]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[18]  Jonathan S. Colton,et al.  The nucleation of microcellular thermoplastic foam with additives: Part I: Theoretical considerations , 1987 .

[19]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[20]  K G Greene,et al.  Development of Technologies Aiding Large‐Tissue Engineering , 1998, Biotechnology progress.

[21]  Anthony Atala,et al.  Synthetic Biodegradable Polymer Scaffolds , 1997, Birkhäuser Boston.

[22]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[23]  Z. Shahrokh,et al.  Characterization, stability, and formulations of basic fibroblast growth factor. , 1996, Pharmaceutical biotechnology.

[24]  W W Minuth,et al.  Tissue engineering and autologous transplant formation: practical approaches with resorbable biomaterials and new cell culture techniques. , 1996, Biomaterials.

[25]  C. Doillon,et al.  Biological molecule-impregnated polyester: an in vivo angiogenesis study. , 1996, Biomaterials.

[26]  R. Langer,et al.  Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. , 1994, Biomaterials.

[27]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[28]  R. Langer.  Delivery systems for angiogenesis stimulators and inhibitors. , 1992, EXS.